Atracurium Besylate Market Overview 2030:
Atracurium besylate is used as an adjunct to general anesthesia during surgeries. It helps facilitate endotracheal intubation and helps relax skeletal muscles. Skeletal muscle relaxation during surgeries is essential for mechanical ventilation for patients. To prevent distress, atracurium besylate is administered after the patient is unconscious. It is a complex molecule and its injection is a nonpyrogenic aqueous solution. In addition, the intravenous administration of atracurium besylate is chosen instead of intramuscular administration to prevent tissue irritation.
COVID-19 Impact Analysis
COVID-19 is an infectious disease that originated in the Hubei province of the Wuhan city in China in late December. The highly contagious disease, caused by a virus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is transmitted from human to human. Since the outbreak in December 2019, the disease has spread to almost 213 countries around the globe with the World Health Organization declaring it a public health emergency on March 11, 2020.
Pharmaceutical and biotech companies together with governments around the globe are working to address the COVID-19 outbreak, from supporting the development of vaccines to planning for medicine supply chain challenges. Currently, around 115 vaccine candidates and 155 molecules are in the R&D pipeline. Moreover, commonly used drugs such as hydroxychloroquine have witnessed a dramatic surge in demand for the management of COVID-19. Such high demand for these drugs has presented huge opportunities for manufacturers of COVID-19 management drugs, as many developed countries are facing a shortage of these drugs. Thus, the pharmaceutical and biotechnology industries are expected to witness significant growth in the future, owing to the demand for vaccines and treatment drugs for COVID-19.
However, with COVID-19 the supply chain of raw materials required to manufacture atracurium besylate has been disrupted in many countries. In addition, the market growth of pharmaceuticals is declining, as manufacturers of drugs have slowed down their production due to the pandemic. This, in turn, is expected to have a significant impact on the atracurium besylate market.
Top Impacting Factors
Rapid technological advancements that help in quick manufacturing of atracurium besylate and increase in government investments in research and development activities in the field of anesthetics have led to the growth of the atracurium besylate market.
In addition, surge in number of medical cases that require surgeries is positively influencing the atracurium besylate market. Atracurium besylate is often used in addition to general anesthesia and aids in mechanical ventilation.
With advanced surgeries that require many hours to finish the use of the atracurium besylate is rising gradually. This is attributed to the fact that atracurium besylate can facilitate endotracheal intubation and lead to relaxation of skeletal muscles during surgeries.
However, some patients might be allergic to atracurium besylate causing anaphylactoid or anaphylactic responses. This factor is impeding the growth of the atracurium besylate market.
Key Market Trends
North America holds a significant share of the atracurium besylate market, as the region has a promising number of skilled healthcare professionals that hold specializations in respiratory support and airway management, which is required to handle atracurium besylate.
Europe holds a major share in the atracurium besylate market due to increase in awareness regarding the use of atracurium besylate in advanced surgeries and the presence of a well-networked pharmaceutical supply chain.
With people developing various forms of chronic illnesses that require surgeries, Asia-Pacific atracurium besylate market is expected to grow during the forecast period. Rise in number of chronic illness cases in this region can be attributed to lifestyle changes.
Major players of the atracurium besylate market are focusing on different strategies such as mergers, acquisitions, and collaborations to come up with better forms of injections and penetrate deeper into the market.
Key Benefits of the Report
- This study presents the analytical depiction of the atracurium besylate industry along with the current trends and future estimations to determine the imminent investment pockets.
- The report presents information related to key drivers, restraints, and opportunities along with a detailed analysis of the atracurium besylate market share.
- The current market is quantitatively analyzed to highlight the market growth scenario.
- Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
- The report provides a detailed analysis depending on competitive intensity and how the competition will take shape in the coming years.
Questions Answered in the Atracurium Besylate Report
- Which are the leading players active in the atracurium besylate market?
- How is each segment of the market expected to grow during the forecast period?
- What are the adoption trends for the atracurium besylate market in emerging economies and established economies across the world?
- What are the current trends that will influence the market in the next few years?
- What are the driving factors, restraints, and opportunities of the market?
- What future projections would help in taking further strategic steps in the market?
- What are the impacts of COVID-19 on the industry?
- What is atracurium besylate?
- What are the current and predicted trends of the market?
Atracurium Besylate Market Report Highlights
| Aspects | Details |
 By Product Type |
|
 By End User |
|
 By Region |
|
 Key Market Players | Baxter Healthcare, Lifespan Biotech Pvt. Ltd., Grindeks AS, Aurobindo Pharma Ltd., Cristalia Produtos Quimicos Farma. Ltd., Jiangsu Hengrui Medicine Co., Ltd., Auro Medics Pharma LLC, NANJING KING-FRIEND, Hana Pharm Co. Ltd., Flagship Biotech International Pvt. Ltd. |
Loading Table Of Content...
